Exercise and Pharmacotherapy for Anxiety in Cardiac Patients

Trial Profile

Exercise and Pharmacotherapy for Anxiety in Cardiac Patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Anxiety
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2017 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2020.
    • 10 Jun 2017 Biomarkers information updated
    • 14 Dec 2015 Planned primary completion date changed from 1 Sep 2019 to 1 Jul 2019, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top